drugset / Trial / NCT06266598

Effectiveness of Antidiabetic Treatment Applied in Childhood Obesity

NCT06266598 ↗

Phase 4 Completed 52 enrolled HÜMEYRA ACIKAN
NaSingle-groupOpen-labelTreatment

Summary

In our study, there are 33 healthy children with normal weight (control group) and 52 obese children who will be treated with metformin. To observe the efficacy of the 3-month treatment before and after metformin treatment, Zn, Zinc α-2 Glycoprotein (ZAG), Peroxisome proliferation activating receptor γ (PPARγ), Leptin (LEP) and Adiponectin (ADIPO) levels were compared, as well as anthropometric measurements and routine biochemistry tests.

Timeline

Start
2019-11-17
Primary completion
2021-08-20
Completion
2021-10-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1000 mg —
Subject Metformin Small molecule 2000 mg —

Indications

No indication recorded.